Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.5000 (0.59%) ($8.5000 - $8.5000) on Wed. May. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.47% (three month average) | RSI | 69 | Latest Price | $8.5000(0.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 4.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(29%) XLRE(28%) SDY(26%) BND(25%) CEMB(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.735% in a week (0% probabilities). VIXM(-26%) VXX(-24%) TLT(-15%) VCIT(-11%) LQD(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.735% (StdDev 3.47%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.48(0.24%) | 10 Day Moving Average | $8.52(-0.23%) | 20 Day Moving Average | $8.07(5.33%) | To recent high | -16.1% | To recent low | 15.3% | Market Cap | $1.5b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |